Business Process Management

PRODUCTS

  • Drive compliance, sterility assurance, and manufacturing efficiency by leveraging the proven advantages of terminal sterilization for your drug products.

  • Ensure Compliance. Safeguard Sterility. Drive Manufacturing Excellence.

  • The Challenge: Building Scalable Viral Vector Programs

    Cell and gene therapies offer unprecedented hope for previously untreatable diseases. At the heart of many of these advanced therapies, including both gene therapies and gene-modified cell therapies, are viral vectors, particularly Adeno-Associated Vectors (AAV) and Lentiviral Vectors (LVV), which serve as crucial gene-delivery vehicles.

  • By combining purpose-built polymers and lipids, animal-origin-free reagents seamlessly blend into the AAV manufacturing process during transfection to dramatically increase AAV titers.

  • New, purpose-built, purpose-driven suite of products in DeltaV Automation Platform connect end-to-end from R&D through commercial manufacturing to get lifesaving therapies to patients faster.

WHITE PAPERS AND CASE STUDIES

NEWS